Back to results
US 10,093,666 B2Granted
Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams
AssigneeArixa Pharmaceuticals, Inc.
InventorEric M. Gordon
Life of this patent
Estimating the term…
Abstract
Provided herein are deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams, pharmaceutical compositions thereof and methods of treating infectious disease with deuterated compounds or pharmaceutical compositions thereof.
Claims25
A compound of Formula (II):
- or a pharmaceutically acceptable salt, hydrate, or solvate, thereof, wherein:
- each of X and Y is independently selected from —CH3 and —CD3;
- at least one of X and Y is —CD3;
- each of R15, R17, and R18 is independently selected from hydrogen and deuterio;
- and
- the level of deuterium enrichment at each position denoted D is at least 50%.
3 more elements
Dependencies are inferred from the claim text.